Investcorp Credit Management BDC, Inc. (ICMB) Stock Analysis and Metrics

Investcorp Credit Management BDC

NASDAQ: ICMB

$0.79 ▲ +0.01 (+1.68%)

At close: Jul 24, 2026 · 3:54 PM UTC

Financial Ratios

Market Cap11.40 Mn

P/E-1.46

P/S0.70

Div. Yield1.07

Total Debt (Qtr)108.11 Mn

Revenue Growth (1y) (Qtr)-18.71

Add ratio to table…

About

Investcorp Credit Management BDC, Inc. is an externally managed non diversified closed end management investment company that has elected to be regulated as a business development company under the Investment Company Act of 1940 and to be treated as a regulated investment company under Subchapter M of the Internal Revenue Code. The company invests primarily in the debt of U. S. middle market companies defined as those with an enterprise value below $750 million. It seeks to generate current income and capital appreciation for its stockholders by making loans and taking equity positions in privately held businesses.

We generate revenue primarily from interest income earned on the debt securities we hold, dividend income from equity warrants and other positions, and various fees such as commitment, origination, structuring, managerial assistance, and consulting fees charged to portfolio companies. In addition, we realize capital gains when we sell or otherwise exit our equity investments in portfolio companies. Our total return to stockholders comes from the combination of current income and appreciation in the value of our loan and equity holdings.

Within the middle market lending arena we compete with other business development companies, private credit funds, commercial and investment banks, commercial finance companies, private equity funds, and hedge funds. Our competitive advantages stem from the extensive experience of our investment team, which includes over 30 years of expertise in middle market financing, and over 100 combined years of structuring capital for business expansion. We benefit from strong relationships with private equity sponsors, investment banks, and other intermediaries that help us source high quality deals. Our affiliation with IVC, a global credit investment platform with $21.3 billion of assets under management, provides additional resources and deal flow. We follow a disciplined underwriting process that emphasizes capital preservation, protective covenants, and risk adjusted returns across credit cycles.

Our borrowers are privately held middle market companies operating across a variety of industries such as professional services, information technology services, insurance, diversified consumer services, commercial services and supplies, trading companies and distributors, specialty retail, containers and packaging, food products, entertainment, health care providers and services, household durables, interactive media and services, consumer staples distribution and retail, software, construction and engineering, automobile components, electronic equipment instruments and components.

Investment Thesis

▲ Bull case

ICMB is positioned to benefit from a strategic portfolio shift toward larger, more stable sponsor-backed credits with strong cash flows, which management is actively pursuing despite muted new deal flow in the broader M&A and LBO environment. The company successfully increased the median EBITDA of its portfolio from $55 million to $61 million quarter-over-quarter while reducing weighted average net leverage from 5.1x to 4.7x, signaling a deliberate upgrade in credit quality and risk-adjusted returns. This focus on core middle-market companies ($15M–$75M EBITDA) with defensible industries and senior secured positions aligns with long-term value creation, especially as ICMB leverages its relationships with sponsors like Trinity Hunt Partners and Genstar Capital to originate club deals directly—more than 50% of transactions now come from this channel. The deployment of $13.1 million across six portfolio companies in Q3 FY25, including secondary investments at attractive prices in firms like Integrity Marketing and Victra, demonstrates disciplined capital allocation even in a tight market, with yields on new debt investments averaging 10.7% and realized IRRs exceeding 11% on exited positions like WIS Corporation (12.9%) and South Coast Terminals (10.7%). These actions reinforce a durable strategy that prioritizes credit selection and proactive management, which could drive sustained NAV growth if deal flow improves, as management expressed optimism about a robust pipeline and continued opportunities in resilient sectors like professional services, insurance, and specialty retail—industries that represented over 29% of the portfolio as of September 2024 and are less sensitive to cyclical downturns. Furthermore, the reversal of non-accrual status on Klein Hersh LLC, which drove a meaningful portion of PIK income, highlights the company’s ability to recover value from challenged assets, turning potential losses into income—a sign of effective workout capabilities that could repeat with other non-accrual positions like Crafty Apes, where further recovery is anticipated.
Despite near-term headwinds, ICMB’s financial structure and liquidity position provide a resilient foundation for opportunistic growth, with net leverage improving to 1.26x as of September 30, 2024, down from 1.35x the prior quarter, and gross leverage at 1.39x—both well within the management-targeted range of 1.25x to 1.5x. This conservative leverage stance, combined with $10.1 million in cash (including $8.3 million restricted) and $52.5 million of unused capacity under the Capital One revolving credit facility, gives the company significant dry powder to deploy capital when attractive opportunities emerge, particularly in secondary markets where ICMB has shown expertise in acquiring loans at favorable terms, as seen with the Integrity Marketing and Victra investments. The company’s ability to generate net investment income of $2.3 million ($0.16 per share) in Q3 FY25—up $1 million sequentially—was driven not only by higher yields but also by mark-to-market gains on performers like Bioplan and Klein Hersh, which together fueled unrealized appreciation. Even as the weighted average yield on the debt portfolio declined to 10.5% due to lower SOFR and tighter spreads, the company maintained income growth through active portfolio turnover, including the full realization of two investments totaling $13.4 million in proceeds with an average IRR of 11.8%. This demonstrates that ICMB can extract value through both income generation and capital recycling, reducing reliance on new origination. Looking ahead, the company’s focus on reducing operating expenses through technological efficiencies and scale benefits—acknowledged by the CEO as a priority—could improve net margins over time as the portfolio grows and fixed costs are spread across a larger asset base, especially if ICMB successfully raises additional capital to increase check sizes and deepen sponsor relationships, which would enhance its relevance in club deals and improve deal flow access.

ICMB is positioned to benefit from a strategic portfolio shift toward larger, more stable sponsor-backed credits with strong cash flows, which management is actively pursuing despite muted new deal flow in the broader M&A and LBO environment. The company successfully increased the median EBITDA of its portfolio from $55 million to $61 million quarter-over-quarter while reducing weighted average net leverage from 5.1x to 4.7x, signaling a deliberate upgrade in credit quality and risk-adjusted returns. This focus on core middle-market companies ($15M–$75M EBITDA) with defensible industries and senior secured positions aligns with long-term value creation, especially as ICMB leverages its relationships with sponsors like Trinity Hunt Partners and Genstar Capital to originate club deals directly—more than 50% of transactions now come from this channel. The deployment of $13.1 million across six portfolio companies in Q3 FY25, including secondary investments at attractive prices in firms like Integrity Marketing and Victra, demonstrates disciplined capital allocation even in a tight market, with yields on new debt investments averaging 10.7% and realized IRRs exceeding 11% on exited positions like WIS Corporation (12.9%) and South Coast Terminals (10.7%). These actions reinforce a durable strategy that prioritizes credit selection and proactive management, which could drive sustained NAV growth if deal flow improves, as management expressed optimism about a robust pipeline and continued opportunities in resilient sectors like professional services, insurance, and specialty retail—industries that represented over 29% of the portfolio as of September 2024 and are less sensitive to cyclical downturns. Furthermore, the reversal of non-accrual status on Klein Hersh LLC, which drove a meaningful portion of PIK income, highlights the company’s ability to recover value from challenged assets, turning potential losses into income—a sign of effective workout capabilities that could repeat with other non-accrual positions like Crafty Apes, where further recovery is anticipated.
Despite near-term headwinds, ICMB’s financial structure and liquidity position provide a resilient foundation for opportunistic growth, with net leverage improving to 1.26x as of September 30, 2024, down from 1.35x the prior quarter, and gross leverage at 1.39x—both well within the management-targeted range of 1.25x to 1.5x. This conservative leverage stance, combined with $10.1 million in cash (including $8.3 million restricted) and $52.5 million of unused capacity under the Capital One revolving credit facility, gives the company significant dry powder to deploy capital when attractive opportunities emerge, particularly in secondary markets where ICMB has shown expertise in acquiring loans at favorable terms, as seen with the Integrity Marketing and Victra investments. The company’s ability to generate net investment income of $2.3 million ($0.16 per share) in Q3 FY25—up $1 million sequentially—was driven not only by higher yields but also by mark-to-market gains on performers like Bioplan and Klein Hersh, which together fueled unrealized appreciation. Even as the weighted average yield on the debt portfolio declined to 10.5% due to lower SOFR and tighter spreads, the company maintained income growth through active portfolio turnover, including the full realization of two investments totaling $13.4 million in proceeds with an average IRR of 11.8%. This demonstrates that ICMB can extract value through both income generation and capital recycling, reducing reliance on new origination. Looking ahead, the company’s focus on reducing operating expenses through technological efficiencies and scale benefits—acknowledged by the CEO as a priority—could improve net margins over time as the portfolio grows and fixed costs are spread across a larger asset base, especially if ICMB successfully raises additional capital to increase check sizes and deepen sponsor relationships, which would enhance its relevance in club deals and improve deal flow access.

▼ Bear case

ICMB faces significant near-term pressure from declining investment income and rising expenses, which are eroding profitability and raising concerns about the sustainability of its distribution policy, as evidenced by the sharp deterioration in financial performance between Q3 FY25 and Q1 FY26. In the quarter ended March 31, 2026, net investment income before taxes plummeted to $0.3 million ($0.02 per share) from $2.3 million ($0.16 per share) just two quarters prior, reflecting a collapse in both interest income (down to $3.05 million from higher levels) and PIK income, while total expenses remained elevated at $3.68 million despite fee waivers. The net decrease in net assets from operations reached ($8.6) million, or ($0.60) per share, driven by a massive $8.8 million in net realized and unrealized losses—largely from mark-to-market depreciation on non-controlled, non-affiliated investments ($7.29 million) and affiliated investments ($1.54 million)—indicating broad portfolio weakness rather than isolated issues. This contrasts sharply with the prior quarter’s strength, where unrealized gains on Bioplan and Klein Hersh fueled NAV growth, suggesting that the company’s performance is highly sensitive to fluctuations in a few large positions, with Bioplan alone representing a $17.4 million position—over 11% of the total portfolio—and any further downgrade could trigger additional losses. The zero new investments in new portfolio companies during Q1 FY26, coupled with only $1.2 million deployed in existing companies, signals a severe pullback in activity that may reflect not just selectivity but a lack of viable opportunities at acceptable risk-adjusted returns, especially as the weighted average yield on debt investments, while reported at 11.95%, is based on fair market value and may not reflect actual cash yield if distressed assets are trading at deep discounts. Furthermore, the company’s reliance on realizations to generate proceeds—$14.0 million in Q1 FY26 from repayments and sales—highlights a potential dependence on portfolio liquidation rather than organic growth, which could shrink the asset base over time and limit scale benefits.
Structural challenges in ICMB’s business model are being exacerbated by external pressures, including declining spreads, floating-rate exposure, and rising funding costs, which are compressing net interest margins and limiting the company’s ability to maintain historical yield levels. The weighted average spread on debt investments fell to 4.3% as of September 2024 from 5.0% the prior quarter, while the weighted average floor declined to 0.9% from 1.0%, directly reducing the yield potential on new loans even as SOFR remains volatile. With 90% of the debt portfolio in floating-rate instruments, any further decline in benchmark rates could pressure income, while the company’s gross leverage of 1.39x and net leverage of 1.26x—though within target—leave little room for error if asset values deteriorate, especially given that 17.5% of the portfolio is in non-debt equity, warrants, and other positions that are more vulnerable to markdowns. The announcement that Houlihan Lokey has been engaged to review strategic alternatives raises unspoken concerns about the viability of the standalone BDC model, as such reviews often precede asset sales, mergers, or liquidation when internal performance fails to meet expectations—a risk amplified by the Board’s November 2024 distribution declaration for December 2024 (payable January 2025) being followed by zero distributions in Q1 FY26, signaling a breakdown in income generation capacity. Additionally, the reduction in the Capital One revolving facility from $100 million to $50 million via the Sixth Amendment, effective May 2026, materially constrains future liquidity and flexibility, limiting the company’s ability to chase deals or support portfolio companies during downturns—a move that may reflect lender caution rather than strategic optimization. Finally, the concentration of risk in a few large positions, combined with a shrinking industry footprint (down to 20 GICS industries from 23 prior quarter) and reliance on sponsor-backed club deals, increases concentration risk; if key sponsors slow deal flow or if core sectors like professional services and insurance face sector-specific headwinds, ICMB could struggle to replace exits with equally attractive investments, leading to a gradual erosion of portfolio quality and income.

ICMB faces significant near-term pressure from declining investment income and rising expenses, which are eroding profitability and raising concerns about the sustainability of its distribution policy, as evidenced by the sharp deterioration in financial performance between Q3 FY25 and Q1 FY26. In the quarter ended March 31, 2026, net investment income before taxes plummeted to $0.3 million ($0.02 per share) from $2.3 million ($0.16 per share) just two quarters prior, reflecting a collapse in both interest income (down to $3.05 million from higher levels) and PIK income, while total expenses remained elevated at $3.68 million despite fee waivers. The net decrease in net assets from operations reached ($8.6) million, or ($0.60) per share, driven by a massive $8.8 million in net realized and unrealized losses—largely from mark-to-market depreciation on non-controlled, non-affiliated investments ($7.29 million) and affiliated investments ($1.54 million)—indicating broad portfolio weakness rather than isolated issues. This contrasts sharply with the prior quarter’s strength, where unrealized gains on Bioplan and Klein Hersh fueled NAV growth, suggesting that the company’s performance is highly sensitive to fluctuations in a few large positions, with Bioplan alone representing a $17.4 million position—over 11% of the total portfolio—and any further downgrade could trigger additional losses. The zero new investments in new portfolio companies during Q1 FY26, coupled with only $1.2 million deployed in existing companies, signals a severe pullback in activity that may reflect not just selectivity but a lack of viable opportunities at acceptable risk-adjusted returns, especially as the weighted average yield on debt investments, while reported at 11.95%, is based on fair market value and may not reflect actual cash yield if distressed assets are trading at deep discounts. Furthermore, the company’s reliance on realizations to generate proceeds—$14.0 million in Q1 FY26 from repayments and sales—highlights a potential dependence on portfolio liquidation rather than organic growth, which could shrink the asset base over time and limit scale benefits.
Structural challenges in ICMB’s business model are being exacerbated by external pressures, including declining spreads, floating-rate exposure, and rising funding costs, which are compressing net interest margins and limiting the company’s ability to maintain historical yield levels. The weighted average spread on debt investments fell to 4.3% as of September 2024 from 5.0% the prior quarter, while the weighted average floor declined to 0.9% from 1.0%, directly reducing the yield potential on new loans even as SOFR remains volatile. With 90% of the debt portfolio in floating-rate instruments, any further decline in benchmark rates could pressure income, while the company’s gross leverage of 1.39x and net leverage of 1.26x—though within target—leave little room for error if asset values deteriorate, especially given that 17.5% of the portfolio is in non-debt equity, warrants, and other positions that are more vulnerable to markdowns. The announcement that Houlihan Lokey has been engaged to review strategic alternatives raises unspoken concerns about the viability of the standalone BDC model, as such reviews often precede asset sales, mergers, or liquidation when internal performance fails to meet expectations—a risk amplified by the Board’s November 2024 distribution declaration for December 2024 (payable January 2025) being followed by zero distributions in Q1 FY26, signaling a breakdown in income generation capacity. Additionally, the reduction in the Capital One revolving facility from $100 million to $50 million via the Sixth Amendment, effective May 2026, materially constrains future liquidity and flexibility, limiting the company’s ability to chase deals or support portfolio companies during downturns—a move that may reflect lender caution rather than strategic optimization. Finally, the concentration of risk in a few large positions, combined with a shrinking industry footprint (down to 20 GICS industries from 23 prior quarter) and reliance on sponsor-backed club deals, increases concentration risk; if key sponsors slow deal flow or if core sectors like professional services and insurance face sector-specific headwinds, ICMB could struggle to replace exits with equally attractive investments, leading to a gradual erosion of portfolio quality and income.

Peer Comparison

Companies in the Asset Management

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	BN	BROOKFIELD Corp /ON/	1,251.90 Bn	1,035.48	16.53	15.06 Bn
2	BLK	BlackRock, Inc.	163.76 Bn	26.19	6.39	20.18 Bn
3	BX	Blackstone Inc.	101.88 Bn	16.71	6.89	13.28 Bn
4	APO	Apollo Global Management, Inc.	73.13 Bn	69.84	2.74	14.22 Bn
5	STT	State Street Corp	51.60 Bn	18.27	3.57	-
6	AMP	Ameriprise Financial Inc	49.37 Bn	12.67	1.77	0.20 Bn
7	NTRS	Northern Trust Corp	33.59 Bn	18.37	6.53	7.84 Bn
8	RJF	Raymond James Financial Inc	33.19 Bn	15.49	2.41	4.66 Bn

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Research Tools

Developers

About

Investment Thesis

Peer Comparison

Create an account

Sign In

Reset Password